Serum biomarkers are promising tools for evaluating patients following traumatic brain injury (tBi). However, their relationship with diffuse histopathology remains unclear. Additionally, translatability is a focus of neurotrauma research, however, studies using translational animal models are limited. Here, we evaluated associations between circulating biomarkers and acute thalamic histopathology in a translational micro pig model of mTBI. Serum samples were collected pre-injury, and 1 min-6 h following mTBI. Markers of neuronal injury (Ubiquitin Carboxy-terminal Hydrolase L1 [UCH-L1]), microglial/macrophage activation (Ionized calcium binding adaptor molecule-1 [Iba-1]) and interleukin-6 [IL-6]) and astrogliosis/astrocyte damage (glial fibrillary acidic protein [GFAP]) were measured. Axonal injury and histological features of neurons and glia were also investigated using immunofluorescent labeling and correlated to serum levels of the associated biomarkers. Consistent with prior experimental and human studies, GFAP, was highest at 6 h post-injury, while no substantial changes were observed in UCH-L1, Iba-1 or IL-6 over 6 h. This study also found promising associations between thalamic glial histological signatures and ensuing release of Iba-1 and GFAP into the circulation. Our findings suggest that in diffuse injury, monitoring serum Iba-1 and GFAP levels can provide clinically relevant insight into the underlying acute pathophysiology and biomarker release kinetics following mTBI, providing previously underappreciated diagnostic capability. Traumatic brain injury (TBI) is an increasing challenge and a global health priority 1 , with more than 50 million TBIs occurring worldwide each year with an associated cost of approximately $400 billion 2. The vast majority (~ 95%) of patients suffer a mild TBI (mTBI) with Glasgow Come Scale (GCS) scores of 13-15 3,4 which, contrary to common perception, cause structural sequelae with variable degrees of injury to neurons, glia, and vascular structures, leading to a spectrum of potential clinical outcomes. As translatability is a primary focus of neurotrauma research, there has been a call for use of higher-order gyrencephalic animal models prior to transitioning to the clinic 5-9 , however, knowledge regarding the TBI-induced pathophysiology in higher order animal models is still limited. Operation Brain Trauma Therapy (OBTT) is a drug-and biomarker-screening